A Novel Missense (M206K) STAT3 Mutation in Diffuse Large B Cell Lymphoma Deregulates STAT3 Signaling

por Hu, Guangzhen, Witzig, Thomas E., Gupta, Mamta
Publicado 2013

Targeting the PD-1 pathway in patients with relapsed classic Hodgkin lymphoma following allogeneic stem cell transplant is safe and effective

por Villasboas, Jose Caetano, Ansell, Stephen M., Witzig, Thomas E.
Publicado 2016

Targeted therapy in lymphoma

por Johnston, Patrick B, Yuan, RuiRong, Cavalli, Franco, Witzig, Thomas E
Publicado 2010

Epstein-Barr Virus Infection in an Elderly Nonimmunocompromised Adult Successfully Treated with Rituximab

por Smeltzer, Jacob P., Howard, Matthew T., Gonsalves, Wilson I., Witzig, Thomas E.
Publicado 2014

Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma

por Nowakowski, Grzegorz S., Feldman, Tatyana, Rimsza, Lisa M., Westin, Jason R., Witzig, Thomas E., Zinzani, Pier Luigi
Publicado 2019

The Tumor Suppressor Protein TRAF3 Modulates GSK3 Activity and Susceptibility of B Lymphoma Cells to GSK3 Inhibition

por Hornick, Emma L., Stunz, Laura L., Sabree, Shakoora, Wu, Xiaosheng, Witzig, Thomas E., Bishop, Gail A.
Publicado 2022

JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis

por Le, Kang, Wellik, Linda E., Maurer, Matthew J., McPhail, Ellen D., Witzig, Thomas E., Gupta, Mamta
Publicado 2021

Differences in Humoral and Cellular Response to COVID-19 Vaccine Against Different Variants over Time in Chronic Lymphocytic Leukemia

por Passerini, Matteo, Ratishvili, Tamar, Kay, Neil E., Temesgen, Zelalem, Witzig, Thomas E., Kennedy, Richard, Parikh, Sameer A.
Publicado 2022

Chronic Eosinophilic Leukemia—Not Otherwise Specified (NOS) in the Background of a Large Cell Lymphoma

por Gonsalves, Wilson I., He, Rong, Pardanani, Animesh, Gupta, Vinay, Smeltzer, Jacob P., Hanson, Curtis A., Witzig, Thomas E.
Publicado 2013

Low hypoxia inducible factor-1α (HIF-1α) expression in testicular germ cell tumors — a major reason for enhanced chemosensitivity?

por Shenoy, Niraj, Dronca, Roxana, Quevedo, Fernando, Boorjian, Stephen A, Cheville, John, Costello, Brian, Kohli, Manish, Witzig, Thomas, Pagliaro, Lance
Publicado 2017

Elevated Serum Lactate in Patients With Lymphoma: It Is Not Always Infection

por Ruan, Gordon J., Gandhi, Sangeetha, Abeykoon, Jithma P., Schram, Susan, Habermann, Thomas M., Sandefur, Benjamin J., Witzig, Thomas E.
Publicado 2021

High Levels of Peripheral Blood Circulating Plasma Cells as a Specific Risk Factor for Progression of Smoldering Multiple Myeloma

por Bianchi, Giada, Kyle, Robert A., Larson, Dirk R., Witzig, Thomas E., Kumar, Shaji, Dispenzieri, Angela, Morice, William G., Rajkumar, S. Vincent
Publicado 2012

ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma

por Nowakowski, Grzegorz S, Chiappella, Annalisa, Witzig, Thomas E, Spina, Michele, Gascoyne, Randy D, Zhang, Lei, Flament, Jocelyne, Repici, Jacqueline, Vitolo, Umberto
Publicado 2016

A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy

por Goswami, Julie, MacArthur, Taleen A., Sridharan, Meera, Pruthi, Rajiv K., McBane, Robert D., Witzig, Thomas E., Park, Myung S.
Publicado 2021

The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells

por Abeykoon, Jithma P., Paludo, Jonas, Nowakowski, Kevin E., Stenson, Mary J., King, Rebecca L., Wellik, Linda E., Wu, Xiaosheng, Witzig, Thomas E.
Publicado 2019

Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials

por Wang, Yucai, Zhou, Shouhao, Qi, Xinyue, Yang, Fang, Maurer, Matthew J., Habermann, Thomas M., Witzig, Thomas E., Wang, Michael L., Nowakowski, Grzegorz S.
Publicado 2022

Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era

por King, Rebecca L., Nowakowski, Grzegorz S., Witzig, Thomas E., Scott, David W., Little, Richard F., Hong, Fangxin, Gascoyne, Randy D., Kahl, Brad S., Macon, William R
Publicado 2018

Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma

por Demosthenous, Christos, Han, Jing Jing, Stenson, Mary J., Maurer, Matthew J., Wellik, Linda E., Link, Brian, Hege, Kristen, Dogan, Ahmet, Sotomayor, Eduardo, Witzig, Thomas, Gupta, Mamta
Publicado 2015

Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma

por Han, Jing Jing, O’byrne, Megan, Stenson, Mary J., Maurer, Matthew J., Wellik, Linda E., Feldman, Andrew L., McPhail, Ellen D., Witzig, Thomas E., Gupta, Mamta
Publicado 2018

Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression

por Bennani, N Nora, Kim, Hyo Jin, Pederson, Levi D, Atherton, Pamela J, Micallef, Ivana N, Thanarajasingam, Gita, Nowakowski, Grzegorz S, Witzig, Thomas, Feldman, Andrew L, Ansell, Stephen M
Publicado 2022